Journal of Virology, February 2000, p. 2052-2056, Vol. 74, No. 4
Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Alberta, Canada T6G 2H7
Received 5 October 1999/Accepted 18 November 1999
Interferon (IFN) is an important immune system molecule capable of
inducing an antiviral state within cells. Herpes simplex virus type
1 (HSV-1) replication is somewhat reduced in tissue culture in
the presence of IFN, presumably due to decreased viral transcription.
Here, we show mutations that inactivate immediate-early (IE) gene
product ICP0 render HSV-1 exquisitely sensitive to IFN inhibition,
resulting in greatly decreased levels of viral mRNA transcripts and the
resulting polypeptides and a severe reduction in plaque formation
ability. Mutations in other HSV-1 genes, including the genes coding for
virion transactivator VP16 and the virion host shutoff protein vhs, IE
gene ICP22, and the protein kinase UL13 gene, do not increase the IFN
sensitivity of HSV-1. Interestingly, ICP0 mutants demonstrate the same
level of sensitivity to IFN as wild-type virus on U2OS cells, an
osteosarcoma cell line that is known to complement mutations in ICP0
and VP16. Thus, in some cell types, functional ICP0 is required for
HSV-1 to efficiently bypass the inhibitory effects of IFN in order to
ensure its replication. The significance of this link between ICP0 and
IFN resistance is discussed.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Herpes Simplex Virus ICP0 Mutants Are
Hypersensitive to Interferon
*
Corresponding author. Mailing address: Department of
Medical Microbiology & Immunology, 1-41, Medical Sciences Bldg.,
University of Alberta, Edmonton, Alberta, Canada T6G 2H7. Phone: (780)
492-2308. Fax: (780) 492-7521. E-mail:
jim.smiley{at}ualberta.ca.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|